Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin

被引:29
作者
Handzlik, Jadwiga [1 ,3 ]
Szymanska, Ewa [1 ]
Alibert, Sandrine [2 ,3 ]
Chevalier, Jacqueline [2 ]
Otrebska, Ewa [1 ,3 ]
Pekala, Elzbieta [1 ]
Pages, Jean-Marie [2 ,3 ]
Kiec-Kononowicz, Katarzyna [1 ,3 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Technol & Biotechnol Drugs, PL-30688 Krakow, Poland
[2] Aix Marseille Univ IRBA, Fac Med & Pharm, UMR Transporteurs Membranaires Chimioresistan & D, F-13385 Marseille 05, France
[3] COST Act BM0701 ATENS, Brussels, Belgium
关键词
Arylideneimidazolidine-2,4-dione; Arylidenehydantoin; Enterobacter aerogenes; Multidrug resistance; Efflux pump; AcrAB-TolC; AROMATIC DERIVATIVES; EFFLUX PUMP; PHENYLPIPERAZINE DERIVATIVES; ARYLPIPERAZINE DERIVATIVES; ANTIARRHYTHMIC PROPERTIES; MULTIDRUG-RESISTANCE; DRUG EFFLUX; STRATEGIES; PHENYTOIN; HYDANTOIN;
D O I
10.1016/j.bmc.2012.10.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of amine-alkyl derivatives of 5-arylidenehydantoin 3-21 was evaluated for their ability to improve antibiotic effectiveness in two strains of Gram-negative Enterobacter aerogenes: the reference strain (ATCC-13048) and the chloramphenicol-resistant derivative over-producing the AcrAB-TolC efflux pump (CM-64). Three antibiotics, chloramphenicol, nalidixic acid and sparfloxacin were used as markers of efflux pump activity. New compounds (5-16) were obtained within 3-4 step synthesis using Knoevenagel condensation, Mitsunobu reaction and microwave aided N-alkylation. Molecular modeling based structure-activity relationship (SAR) studies were performed. The most active compounds: (Z)-5-(4-(diethylamino) benzylidene)-3-(2-hydroxy-3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)imidazolidine-2,4-dione (14) and (Z)-5-(2,4-dimethoxybenzylidene)-3-(2-hydroxy-3-(isopropylamino)propyl)imidazolidine-2,4-dione (15) induced fourfold decrease of minimal inhibition concentration (MIC) of all tested antibiotics in the strain CM-64 overexpressing the AcrAB-TolC pump. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 31 条
[21]   Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria [J].
Pages, Jean-Marie ;
Amaral, Leonard .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (05) :826-833
[22]   Synthesis, structure-activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives [J].
Pekala, E ;
Stadnicka, K ;
Broda, A ;
Zygmunt, M ;
Filipek, B ;
Kiec-Kononowicz, K .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (03) :259-269
[23]   Microbial drug efflux proteins of the major facilitator superfamily [J].
Saidijam, Massoud ;
Benedetti, Giulia ;
Ren, Qinghu ;
Xu, Zhiqiang ;
Hoyle, Christopher J. ;
Palmer, Sarah L. ;
Ward, Alison ;
Bettaney, Kim E. ;
Szakonyi, Gerda ;
Meuller, Johan ;
Morrison, Scott ;
Pos, Martin K. ;
Butaye, Patrick ;
Walravens, Karl ;
Langton, Kate ;
Herbert, Richard B. ;
Skurray, Ronald A. ;
Paulsen, Ian T. ;
O'Reilly, John ;
Rutherford, Nicholas G. ;
Brown, Melissa H. ;
Bill, Roslyn M. ;
Henderson, Peter J. F. .
CURRENT DRUG TARGETS, 2006, 7 (07) :793-811
[24]  
Sau-Fun T, 1990, J PHYS ORG CHEM, V3, P559
[25]   Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity [J].
Subtel'na, Ivanna ;
Atamanyuk, Dmytro ;
Szymanska, Ewa ;
Kiec-Kononowicz, Katarzyna ;
Zimenkovsky, Borys ;
Vasylenko, Olexandr ;
Gzella, Andrzej ;
Lesyk, Roman .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) :5090-5102
[26]   Antimicrobial activity of 5-arylidene aromatic derivatives of hydantoin. Part 2 [J].
Szymanska, E ;
Kiec-Kononowicz, K ;
Bialecka, A ;
Kasprowicz, A .
FARMACO, 2002, 57 (01) :39-44
[27]   Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin [J].
Szymanska, E ;
Kiec-Kononowicz, K .
FARMACO, 2002, 57 (05) :355-362
[28]   (Z)-5-ARYLMETHYLENEHYDANTOINS AND (E)-5-ARYLMETHYLENEHYDANTOINS - SPECTROSCOPIC PROPERTIES AND CONFIGURATION ASSIGNMENT [J].
TAN, SF ;
ANG, KP ;
FONG, YF .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1986, (12) :1941-1944
[29]   The medicinal chemistry of multidrug resistance (MDR) reversing drugs [J].
Teodori, E ;
Dei, S ;
Scapecchi, S ;
Gualtieri, F .
FARMACO, 2002, 57 (05) :385-415
[30]  
Wojciechowska-Karolak J., 2009, J MOL STRUCT, V930, P126